Atlas Trials

Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia

Clinical trial NCT07206823 · RECRUITING

Trial details

NCT number
NCT07206823
Sponsor
The First Affiliated Hospital of Soochow University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Primacy Immune Thrombocytopenia
Start date
2025-09-01
Primary completion
2027-02-28
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.